Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran

[1]  A. Farahani,et al.  Frequency of mutations associated with isoniazid-resistant in clinical Mycobacterium tuberculosis strains by low-cost and density (LCD) DNA microarrays , 2016 .

[2]  A. Farahani,et al.  Mycobacterium tuberculosis Beijing Genotype in Western Iran: Distribution and Drug Resistance. , 2016, Journal of clinical and diagnostic research : JCDR.

[3]  M. Masjedi,et al.  Factors Associated with Health-Related Quality of Life in Tuberculosis Patients Referred to the National Research Institute of Tuberculosis and Lung Disease in Tehran , 2015, Tuberculosis and respiratory diseases.

[4]  S. Kundu,et al.  A STUDY TO EVALUATE PATTERN OF RIFAMPICIN RESISTANCE IN CASES OF SPUTUM POSITIVE PULMONARY TUBERCULOSIS , 2015 .

[5]  A. Farahani,et al.  Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. , 2014, Microbial drug resistance.

[6]  A. Farahani,et al.  Anti Tuberculosis Drug Resistance in West of Iran , 2014, Journal of global infectious diseases.

[7]  S. Jang,et al.  A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice. , 2014, Journal of thoracic disease.

[8]  J. Klausner,et al.  Mixed Mycobacterium tuberculosis Complex Infections and False-Negative Results for Rifampin Resistance by GeneXpert MTB/RIF Are Associated with Poor Clinical Outcomes , 2014, Journal of Clinical Microbiology.

[9]  Nalin Rastogi,et al.  Current Methods in the Molecular Typing of Mycobacterium tuberculosis and Other Mycobacteria , 2014, BioMed research international.

[10]  M. Nicol,et al.  GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting , 2013, Journal of Clinical Microbiology.

[11]  J. Farrar,et al.  Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis , 2013, Journal of Clinical Microbiology.

[12]  F. Altice,et al.  The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia , 2013, PloS one.

[13]  T. Marras,et al.  Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  P. V. van Helden,et al.  Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  N. El-Khizzi,et al.  Evaluation of direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory clinical specimens using the Cepheid Gene Xpert® system. , 2012, Saudi medical journal.

[16]  Anna Vassall,et al.  Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis , 2011, PLoS medicine.

[17]  S. Lawn,et al.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. , 2011, Future microbiology.

[18]  C. Çavuşoğlu,et al.  Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens , 2011, Journal of Clinical Microbiology.

[19]  M. Perkins,et al.  Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study , 2011, The Lancet.

[20]  S. Rüsch-Gerdes,et al.  Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System , 2011, Journal of Clinical Microbiology.

[21]  K. Winthrop,et al.  Isolation of non-tuberculous mycobacteria from the sputum of patients with active tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  Pan‐Chyr Yang,et al.  Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. , 2009, Respiratory medicine.

[23]  D. van Soolingen,et al.  Drug Susceptibility Testing of Mycobacterium tuberculosis Complex by Use of a High-Throughput, Reproducible, Absolute Concentration Method , 2007, Journal of Clinical Microbiology.

[24]  S. Hoffner,et al.  Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  F. Drobniewski,et al.  The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story. , 1998, Journal of medical microbiology.